Voloridge Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Voloridge Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-101,513	Closed	-$16.8M	–	1990
2021 Q2	$16.8M	Buy	101,513 +76,729	+310%	+$12.8M	0.12%	229
2021 Q1	$3.8M	Buy	+24,784	New	+$3.37M	0.03%	614
2020 Q1	–	Sell	-21,942	Closed	-$2.44M	–	1517
2019 Q4	$2.44M	Buy	+21,942	New	+$2.26M	0.05%	443
2019 Q2	–	Sell	-4,019	Closed	-$443K	–	1199
2019 Q1	$443K	Buy	+4,019	New	+$420K	0.01%	696
2018 Q1	–	Sell	-83,485	Closed	-$7.6M	–	703
2017 Q4	$7.6M	Buy	+83,485	New	+$6.94M	0.17%	146

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Voloridge Investment Management's PRAH Position: Q3 2021 in Review

Voloridge Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 101,513 shares — an estimated $16.8M sold.

Voloridge Investment Management first reported a position in PRAH in Q4 2017 and held it in 5 quarters. The position peaked at $16.8M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Voloridge Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Voloridge Investment Management sold 101,513 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $16.8M.
Voloridge Investment Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 5 quarters.
Voloridge Investment Management's PRA Health Sciences, Inc. position peaked at $16.8M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.